Capital Investment Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Investment Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.4K	Sell	272 -40	-13%	-$8.62K	﹤0.01%	887
2026 Q1	$62.6K	Buy	312 +10	+3%	+$2.07K	﹤0.01%	819
2025 Q4	$62.3K	Buy	302 +121	+67%	+$24.2K	﹤0.01%	787
2025 Q3	$32.4K	Buy	181 +70	+63%	+$11.9K	﹤0.01%	840
2025 Q2	$17.9K	Sell	111 -242	-69%	-$38.5K	﹤0.01%	887
2025 Q1	$60.1K	Sell	353 -21	-6%	-$3.65K	0.01%	684
2024 Q4	$62.2K	Buy	374 +2	+0.5%	+$342	0.01%	629
2024 Q3	$63.9K	Hold	372	–	–	0.01%	647
2024 Q2	$57.2K	Hold	372	–	–	0.01%	643
2024 Q1	$57.2K	Sell	372 -286	-43%	-$43.6K	0.01%	637
2023 Q4	$104K	Sell	658 -282	-30%	-$40.5K	0.01%	577
2023 Q3	$138K	Hold	940	–	–	0.01%	519
2023 Q2	$144K	Buy	940 +35	+4%	+$5.46K	0.01%	499
2023 Q1	$140K	Hold	905	–	–	0.02%	500
2022 Q4	$139K	Buy	905 +566	+167%	+$83.5K	0.02%	504
2022 Q3	$45K	Hold	339	–	–	0.01%	581
2022 Q2	$46K	Hold	339	–	–	0.01%	599
2022 Q1	$51K	Buy	+339	New	+$50.1K	0.01%	623
2021 Q3	–	Sell	-349	Closed	-$60K	–	773
2021 Q2	$60K	Buy	+349	New	+$57.6K	0.01%	572
2021 Q1	–	Sell	-445	Closed	-$75K	–	740
2020 Q4	$75K	Buy	445 +285	+178%	+$46.2K	0.01%	483
2020 Q3	$25K	Buy	160 +150	+1,500%	+$24.5K	﹤0.01%	491
2020 Q2	$2K	Hold	10	–	–	﹤0.01%	542
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	547
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	537
2019 Q3	$1K	Buy	10 +3	+43%	+$399	﹤0.01%	1317
2019 Q2	$1K	Buy	7 +5	+250%	+$690	﹤0.01%	1332
2019 Q1	$0	Buy	+2	New	+$288	﹤0.01%	1223

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Capital Investment Advisory Services's FBT Position: Q2 2026 in Review

Capital Investment Advisory Services reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 13% in Q2 2026, selling an estimated $8.62K and leaving 272 shares worth $67.4K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Capital Investment Advisory Services first reported a position in FBT in Q1 2019 and has held it in 27 quarters since. The position peaked at $144K in Q2 2023. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Capital Investment Advisory Services held 272 shares of First Trust NYSE Arca Biotechnology Index Fund worth $67.4K as of Q2 2026.
Capital Investment Advisory Services sold 40 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $8.62K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q2 2026, its #887 holding.
Capital Investment Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 27 quarters since.
Capital Investment Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $144K in Q2 2023.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.